Skip to main content

FO (Fenofibrate 145 mg)

Pill with imprint FO is White, Elliptical/Oval and has been identified as Fenofibrate 145 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for FO

Fenofibrate 145 mg FO


145 mg
18.00 mm
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Inactive Ingredients
hypromellose 2910 (3 mPa.s), docusate sodium, sucrose, sodium lauryl sulfate, lactose monohydrate, microcrystalline cellulose, magnesium stearate, polyvinyl alcohol, titanium dioxide, magnesium silicate, soya lecithin, xanthan gum

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-7756 (Discontinued) Teva Pharmaceuticals USA, Inc.
68382-0270 Zydus Pharmaceuticals (USA) Inc.
00074-3189 Abbott Laboratories

Get help with Imprint Code FAQs.

Related images for "FO"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.